Services Oncaspar Supplier

Oncaspar Supplier

Derek Clarke is a supplier of Oncaspar to healthcare professionals around the world.


Oncaspar (pegaspargase, Sigma Tau) is indicated as a component of a multi-agent chemotherapeutic regimen for the first line treatment of patients with acute lymphoblastic leukemia (ALL) and for the treatment of patients with ALL and hypersensitivity to native forms of L-asparaginase.


Oncaspar is the only approved pegylated formulation approved by the US Food and Drug Administration (FDA) of L-asparaginase, the enzyme that depletes the amino acid asparagine. While normal cells can produce asparagine, leukemic cells are unable to produce enough asparagine to survive on their own.


L-asparaginase is given to ALL patients to ensure depletion of asparagine that is circulating in the blood. Depletion (starving the leukemic cells) of asparagine ultimately results in leukemic cell death.


Oncaspar is administered through intramuscular (IM) injection or intravenous (IV) infusion.


Derek Clarke, with more than 30 years as experience as an exporter of both branded and generics medicines, is able to source and supply products, often unavailable through other sources, quickly and efficiently.


Please contact us for more information on our Oncaspar supplies.


+44 (0) 208 952 2061